WCM Investment Management
PTCT icon

WCM Investment Management’s PTC Therapeutics PTCT Stock Holding History

WCM Investment Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.22M Sell
94,687
-15,580
-14% -$1.1M 0.01% 176
2025
Q4 		$8.4M Sell
110,267
-36,798
-25% -$2.67M 0.02% 159
2025
Q3 		$8.92M Buy
+147,065
New +$7.66M 0.02% 147

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

WCM Investment Management's PTCT Position: Q1 2026 in Review

WCM Investment Management reduced its PTC Therapeutics (PTCT) stake by 14% in Q1 2026, selling an estimated $1.1M and leaving 94,687 shares worth $6.22M. The position accounts for 0.01% of the portfolio, ranked #176.

WCM Investment Management first reported a position in PTCT in Q3 2025 and has held it in 3 quarters since. The position peaked at $8.92M in Q3 2025. 351 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • WCM Investment Management held 94,687 shares of PTC Therapeutics worth $6.22M as of Q1 2026.
  • WCM Investment Management sold 15,580 PTC Therapeutics shares in Q1 2026, an estimated $1.1M.
  • PTC Therapeutics made up 0.01% of WCM Investment Management's portfolio in Q1 2026, its #176 holding.
  • WCM Investment Management first reported a position in PTC Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • WCM Investment Management's PTC Therapeutics position peaked at $8.92M in Q3 2025.
  • 351 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on WCM Investment Management's 13F filing for Q1 2026, filed 7 May 2026.